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CHAPTER I

INTRODUCTION AND LITERATURE REVIEW

A.

LEAD INTOXICATION
Lead poisoning usually results from the ingestion of lead-contain-

ing substances such as water which has stood in lead pipes, lead-base
paint, and objects containing lead solder or from the inhalation of
fumes containing volatilized lead from burning storage batteries.
Other means which inadvertently lead to lead poisoning include the imbibing of illicit ("corn") \vhiskey contaminated by lead solder in the
pipes of the still or victims surviving gun-shot 1._:rounds who retain the
embedded pellets (bullets or buckshot) which can cause poisoning many
years later after entrapment in a serous cavity.

As a rule, absorption

by any route is slow, and prolonged exposure is necessary for the development of symptoms.
According to Bennett and Poskanzer

(1970)~

Lead is an example of

a cumulative poison which is slowly excreted and is almost never seen
or described as an acute poison.
after chronic exposure.

Symptoms develop slowly, but mostly

Lead which is absorbed is deposited in

bones as elemental lead and is metabolized in a rnanner similar to that
of calcium.

Under such chronic conditions, blood, urine, and feces

levels are very low.

According to the aforementioned physicians, once

the source of the abnormal absorption of lead has been terminated,

1

2
virtually all of the lead in the body is directed into bone.

They

finally note that it requires approximately t1.;ice the time to excrete
a given burden of lead as it does to accumulate it.
B.

BONE REHODELING
Krook, Shively, Duncan, and Pond (1973) agreed with Whalen, Win-

chester, Krook, Dische, and Nunez (1971) in their observations on lead
intoxicated animals in regards to the remodeling of bone that the physiological resorption, specifically of metaphyseal trabeculae, occurred
mainly by osteocytic osteolysis, a pathologic-physiologic process reviewed by Belanger (1969).

Osteolysis is defined as an internal re-

sorption of bone centered around the activity of deep-seated osteocytes.
It has been shmm repeatedly by Belanger (1965, 1968, 1970), Belanger,
Semba, Tolnai, Copp, Krook, and Gries (1966), Brown, Krook, and Pond

(1966), and Henrikson (1968) that osteolysis is the primary mechanism
in bone resorption, both under physiologic conditions and in diseases
characterized by excessive resorption.
This deep seated bone-resorption has been related by some
authors to the death of the osteocyte.
this phenomenon as passive.

Most of them have interpreted

Pritchard wrote in 1956

~the

osteocyte is

an essential constituent of bone, for when the cells die, the matrix
around them, although persisting for a time, eventually crumbles and
is removed to be replaced by living bone".
Rutishauser and Majno (1951) have recognized perilacunar resorption as a result of cellular activity.
necrosis".

They called it "physiological

These authors described the phenomenon as occurring "at the

3

center of the trabeculae" in spongy bone and "at the periphery of the
Haversian systems" in compact bone.

The dying cells often show a "split-

ting nucleus" and "reappearance of alkaline phosphatase".
Whalen, et al., (1971) and Krook, et al., (1973) concluded that
the initial bone lesion in these animals was the result of the inhibition
of osteocytic activity resulting in a widening of the trabeculae, eventual necrosis of osteocytes with the now dead bone tissue becoming the
object of osteoclasia.

Osteoclasia is a secondary phenomena involved

in the removal of already altered bone such as occurs in necrosis from
fractures or from bone altered by osteolysis (Belanger, Semba, Copp,
Tolnai, Krook, and Gries, 1966).
C.

PARATHYROID HORMONE AND CORTICOSTEROIDS
While the physiological and pharmacological effects of parathyroid

hormone (PTH) and hydrocortisone (cortisol) on bone have been documented
and are thus well known, their precise mechanisms of action remain ellusive and have yet to be illucidated after more than three decades of
intense investigation (Albright and Reifenstein, 1948; Milne, 1951;
Dent, 1953; Sissons and Hadfield, 1955; Silberberg and Silberberg, 1956;
Talmage, 1956; Bernick and Ershoff, 1963; Arnaud, 1967; Copp, 1970;
Burns, 1974; Daughaday, 1975; Guyton, 1976).
Parathyroid hormone (PTH) controls body fluid calcium levels principally by regulating the removal of calcium from bone.

After PTH ad-

ministration, marked elevations in plasma calcium levels occur within
several hours (Talmage, 1969).

PTH stimulates osteoclast activity in

vitro (Holtrop, Raisz, and Simons 1974), increases osteoclast populations
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in vivo (Tatevossian, 1973), and accelerates the rate of skeletal remodeling (Heller, McLean, and Bloom, 1950).
Systemically, corticosteroids affects a wide variety of metabolic
processes.

The deleterious affect they have on bone (Winter, Silberberg,

and Stoerk, 1950; Follis, 1951; Sissons and Hadfield_ 1955; Silberberg
and Silberberg, 1956; Laron, Muhlethaller, and

Klein~

Ershoff, 1963), ground substance (Seifter, Ehrich,

1958; Bernick and

~oeder,

~uth,

and

Hauser, 1953; Sobel, Gabay, and Johnson, 1958), and fibroblastic activity (Baker and Whitaker, 1950; Sissons and Hadfield, 1951; Gerarde and
Jones, 1953), and their inhibition of the inflammatory reaction are
well documented.
Roberts in 1969 and Kenner in 1970 found that the effect of cortisol on bone is dose and time dependent.

Low doses of cortisol (1-5

mg/kg/day)stimulate bone resorption and high doses of cortisol (20-75
mg/kg/day) inhibit bone resorption.
the bone volume by

~ncreasing

the number of osteoblasts.

The low doses of cortisol reduced

the number of osteoclasts and decreasing

Over a long time period any dosage over

2.0 mg/kg/day inhibits bone resorption (Roberts, 1969).

In these ex-

periments Roberts also noted that at low doses the corticosteroid action is characterized by increased progenitor cell proliferation, increased number of osteoclasts, and increased resorption of alveolar
bone.

At the higher dose levels, progenitor cell proliferation and

bone formation were depressed without any evidence of increased resorption of the alveolar bone,

These findings suggest two antagonistic

mechanisms; 1) direct inhibition of progenitor cell proliferation by

5

cortisol and 2) inducement of a secondary hyperparathyroidism by cortisol which results in increased bone resorption.
Corticosteroids reduce serum calcium levels and also have an antiproliferative action on cells.

It has been suggested that the increased

numbers of precursor cells and osteoclasts is a result of the increase
in PTH secretion (Talmage, 1969) caused by the lowered serum calcium
after the administration of cortisol (Storry, 1960; Stoerk, Peterson,
and Jelinek, 1963; Gordan, Hansen, and Lubick, 1967; Rasmussen, 1968).
Roberts also states that the high dose levels of corticosteroid
blocks the parathyroid mediated effect (the increased osteoclasts and
bone resorption) by inhibiting parathyroid hormone-stimulated proliferation of fibroblasts.

It is also possible that high doses of cortisol

could act directly upon the parathyroid glands and depress the secretion of PTH.
In an early study of the interrelationship between cortisone and
parathyroid extract in rats, Laron, Muhlethaler, and Klein (1958) generally summarized that an excess of parathyroid hormone caused changes
in teeth and bone, and it also induced hypercalcemia and nephrocalcinosis.

They further stated that cortisol also produced changes in bone,

but those changes manifested were different from those induced by an
excess of parathyroid hormone.

Cortisol produces hypercalcuria without

causing hypercalcemia, and, according to Pincus, Natelson, and Lugovoy
(1951), it may even reduce normal concentrations of serum calcium; it
has been used to reduce elevated serum calcium levels in hypervitaminosis D (vitamin D poisoning), infantile hypercalcemia, and sarcoidosis.
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On the other hand, Dent (1956) claimed that cortisone was ineffective
in lowering the hypercalcemia of hyperparathyroidism in man.
Parathyroid hormone is a polypeptide with a molecular weight of
approximately 8500 whose main and perhaps only function is the maintenance of calcium homeostasis.

On the other hand, hydrocortisone is

classified as a steroid with a structural nucleus common to all derivatives of this group: the perhydropentanophenanthreoe structure, with a
molecular weight of approximately 232.84, being essentially derived
from a cholesterol precursor (Figures I-1, I-2).
Unlike parathyroid hormone, whose release is primarily determined
by perfusing glandular serum levels of calcium, it is now known that
cortisone and hydrocortisone are regulated by a series of feedback mechanisms involving other endocrine and associated structures: the hypothalamus and pituitary gland.

The one thing they do have in common is their

initial reaction with a specific receptor located in the membrane as is
the case of the former (Rasmussen, 1970, 1971) or in the cytoplasm by
the latter (Burns, 1974).

In both cases, the receptor sites tend to

have a conformational structure complementary to the structure of the
hormone allowing it to combine or conjugate to the former with a high
degree of affinity.

It, therefore appears that two major systems exist

which tend to help explain most hormonal action

mec~anisms

with the ex-

ception of insulin and thyroid hormone whose effects on metabolic activity
in practically all cells remain obscure.
D.

MECHANISM OF ACTION OF
1.

H0~10NES

Adenyl Cyclase - Cyclic Adenosinemonophosphate System
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Figure l-1

Perhydropentanophenanthrene nucleus
(completely saturated multicyclic structure).

Figure I-2

Hydrocortisone (Cortisol)
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The nucleotide adenosine 3',5'-monophosphate (c-AMP) is now recognized as the key mediator in the action of many processes in the animal
and plant kingdoms.

It was largely through the patient, painstaking

investigations of Sutherland and his coworkers over the last 20 years,
summarized in a lecture delivered when he received the Nobel Prize in
Physiology in Stockholm, Sweden, in December, 1971, that heralded the
rivalry of c-AMP to adenosinetriphosphate (ATP) in the biological world
(Sutherland, 1972).

Since that time, investigations on the role of

c-AJW have developed enormously.

Not only is c-AMP found in the cells

of all animal tissues studied, but it has been recently identified in
bacteria as a necessary element for the induction of

~ertain

enzymes.

It has also been identified as an attractant substance for such organisms
as amoeba and the slime mold causing them to aggregate.
In 1957 Sutherland and Rall reported that
effects of epinephrine on liver phosphorylase.

cycli~

AMP mediates the

Subsequent studies

(Robinson, Butcher, and Sutherland, 1968) have shown that the physiological actions of many other hormones and biologically active substances
such as corticotrophin, thyrotrophin,

serotonin~

vasopressin, and lu-

teinizing hormone are also mediated by this nucleotide.

Interaction of

these substances with their respective target cells leads to activation
of adenyl cyclase, a membrane-bound enzyme that catalyzes the conversion
of adenosine triphosphate to cyclic AMP.

The

cycli~

AMP produced affects

other cellular processes, such as activation, induction, or secretion of
enzymes, active transport of ions across cellular membranes, or release
of other hormones.

Activation of the particular system involved causes

9
the physiological response attributed to the hormone.

In many instances

the intracellular process stimulated by cyclic AMP is still unknown (Aurbach, Potts, Chase, and Melson, 1969).
Parathyroid hormone causes a marked increase in activity of adenyl
cyclase from renal cortex (Chase and Aurbach,

1968)~

isolated renal cor-

tical tubules (Melson, Chase, and Aurbach, 1968), fetal rat calvaria and
iliac bone from mature rats (Chase, Fedak, and Aurbach, 1969).

Signifi-

cant stimulation of the enzyme can be detected within 15 seconds after
adding PTH to the test systems previously mentioned.
earliest response to PTH that has been

observed~

This change is the

and the enzyme in iso-

lated tubules from renal cortex is sensitive to the hormone at very low
concentrations (0.05 ~g/ml).
Certain hormones activate adenyl cyclase in brain, adrenal, thyroid, and skeletal muscle but not in bone and kidney.

In contrast, para-

thyroid hormone causes stimulation of the enzyme onLy in the latter tissues (Chase, Fedak, and Aurbach, 1969).

Parathyroid hormone affects

adenyl cyclase only in tissues where it has a known physiological function.
It is apparent from data presented by

Aurba~h,

Potts~

Chase, and

l1elson in 1969 that cyclic AMP is a mediator in the mechanism of action
of parathyroid hormone and that the metabolic

pro~esses

leading to the

observed physiological effects of the hormone on both bone and kidney
are initiated by a common mechanism: stimulation of adenyl cyclase. The
exact intracellular metabolic processes affected by cyclic AMP in renal
and skeletal tissue are unknown.
The manner in which

c-Al~

mediates hormonal activity appears to
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be constant for parathyroid hormone in all mammalian species studied
so far.

It has been dubbed a "second messenger 1' .

Visualize PTH as

the first messenger, circulating in the plasma, encountering and subsequently interacting with a specific receptor in the plasma membrane of
the target cell.

The receptor [possibly linked to or an integral part

of the enzyme adenyl cyclase (AC)], which imparts specificity, interacts
with PTH, thus activating AC, which in turn catalyzes the formation of
c-AMP from ATP.

The ne\vly formed c-AMP then activates or triggers the

response characteristic of and recognized as the biological action of
PTH.

As a part of nature's "checks-and-balances", or homeostatic mech-

anism, the activity of c-AHP is regulated by a potent enzyme known as
phosphodiesterase.

This cyclic nucleotide phosphodiesterase, found in

the particulate and soluble fractions of the cell, catalyzes the hydrolysis of cyclic M1P to adenosine 5 1 -monophosphate.

Inhibition of the

phosphodiesterase also causes increased intracellular concentration of
cyclic AMP, but so far no hormone has been found to be an inhibitor of
this enzyme (Aurbach, Potts, Chase, and Melson, 1969).

A schematic rep-

resentation of this second messenger may be seen in Figure I-3 (modified after Sutherland, 1972).
2.

Cytoplasmic Receptor-Nuclear Acceptor

Syste~

According to Burns (1974), all of the steroid hormones exert their
metabolic effects, more or less, through this

syste~.

Jt is hypothesized

that these steroids are capable of penetrating the celL mambrane and combining with a highly specific protein receptor in the cytoplasm.

This

conjugated steroid-receptor complex, in turn, is transLocated to the

Figure I - 3

Adenyl Cyclase - c-AMP System

Cell
Membrane

Triggers Physiologic
Response of PTH

Kinase

Stimulus

\II
Parathyroid
Glands

Adenyl
Cyclase

,,,
Released PTH
(First Messenger)

AMP

(Inactivation of C-AMP
by Phosphodiesterase)

~

I-'
I-'
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nucleus which enters to then combine with specific acceptors located on
chromatin.

This complex steroid-receptor-acceptor now causes nuclear

genetic material to produce messenger ribose nucleic acid (m-RNA), which
now signals and directs the fabrication of some highly specific enzyme
whose action is directly responsible for producing the physiologic expression of the hormone's activity.

Specificity of this system resides

in the conformational structure of the receptor protein to the steroid
hormone and this complex condensing to the nuclear chromatin acceptor.
This system may be visualized in Figure I-4 (modified after Burns, 1974).
E.

STATEMENT OF THE PROBLEM
Since a number of investigations (previously cited) have been

reported where varying doses of PTH and cortisol were used over rather
extended periods of time it seemed reasonable to conduct a short-term
study using relatively high doses of the two hormones, but administering
them at broader time intervals.

In other words, all test animals to be

studied would be already rendered lead-intoxicated before they would be
·challenged by PTH, cortisol, and a combination of the two, and at some
subsequent point in time, sacrificed.

Bone tissue sections and blood

samples will be examined in order to determine whether or not any changes
occurred during the acute experimental period that might parallel those
of the aforementioned chronic studies.

Figure I-4
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CHAPTER II
MATERIALS AND METHODS
A.

EXPERIMENTAL ANIMALS
Twenty-eight, young, adult, male, Sprague-Dawley rats, whose

weights ranged from 174 to 311 grams, were used in this investigation.
Upon receipt, the animals were allowed to become acclimated to their
new environment and fed a normal diet of Purina Fox Chow pellets with
water allowed ad libitum.
Following this seven day acclimation period, the animals were
then maintained on a diet consisting of ground Purina Chow meal, and
again a free intake of water.

Lead (Ph) intoxication was induced by

the addition of 1000 parts per million of the acetate [Pb(COOCH ) ;
3 2
per cent Pb = 63.71; Aldrich Chemical Co.] to the meal.

Calcium and

phosphate carriers were also added to the diet in 1.1% and 1.0%
amounts respectively.

All animals were maintained on this diet for

the entire two week experimental period.

The animals were then divided

into four groups and kept on the aforementioned lead, calcium, and phosphate diet for a period of seven days.
B.

EXPERIMENTAL PROTOCOL
The treatment for the four groups was as follows;
1.

One animal was selected from each group immediately
prior to the administration of the test drugs for
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blood samples in order to determine pre-injection
levels of calcium, phosphate, and lead.
samples (10 ml

Blood

each) were obtained by cardiac

puncture and the ca++ and Pi were determined by
SNA- 12/80, and the Pb by the dithizone urinalysis
method modified for blood analysis (Race, 1978).
Those rats surviving were no longer used in this
investigation.

2.

Exactly 1 week following placement of the anlinals
on the lead-intoxicating diet, on which they were
maintained through the remainder of the study, injections were begun:
Table II-1
Experimental Groups
Group

Drugs

No. of Rats
~

2.0 ml

0.9%

Group I

6

Controls
saline

Group I I

6

Parathyroid Hormone (Lilly)2.0 ml(l ml = 100 USP units)

Group I I I

6

Hydro-Cortisone acetate (CalBiochem-Behring) - 2.0 ml
(1 ml = 2.5 mg)

Group IV

6

1 ml
1 ml

Parathyroid Hormone plus
Hydro-Cortisone acetate

All drugs were administered via intraperitoneal injection
on days 1,3,5, and 7.

Each animal was weighed on day 1

before the administration of the test drugs for its group
and at the end of day 8 which marked the termination of
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the experimental period.

Prior to sacrificing, one animal

was selected from each group from which blood samples were
again obtained for ca++, Pi, and Pb determinations.
C.

POST MORTEM PREPARATION OF STUDY SPECI}illNS
Sacrificing consisted of etherization in a large glass desic-

cator followed by pneumothorax.

Immediately following sacrificing,

surgical dissection was used to obtain tissue samples:
1.

Alveolar process - buccal to mandibular first molar

2.

Condyle of the mandible

3.

Fourth rib

4.

Femur (head)

All soft tissue attachments were manually removed, and the formentioned
specimen placed in 10% neutral formalin for fixation and storage for a
period of 90 days.

Following fixation, the specimens were rinsed several

times with distilled water and then placed in a 5% H2 so4 solution containing 5% Na 2 S04, for decalcification (Gomori, 1952) for a period of
3 weeks.

The decalcified samples were removed from this solution,

rinsed with distilled water and then embedded in paraffin for sectioning
and staining.
D.

STAINING PROCEDURES
a.

Hematoxylin and eosin

b.

Rhodizonate (method for lead salts)
Sections were placed in a 0.2% solution of sodium rhodizonate
(Sigma) in 1% acetic acid for 60 minutes, then counter stained
with 0.1% light green S.F. in 1% acetic acid for 30 seconds.
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All sections were permanently mounted and subjected to light microscopic study and evaluation which is reported and discussed in subsequent chapters.

CHAPTER III

RESULTS

A.

HEIGHT DATA
Upon receiving the twenty-eight experimental animals they were

divided into four groups, each group containing seven rats,

After the

one week acclimation period the rats were placed on the experimental
diet as described in Chapter II: Materials and Hethods.

At the end of

seven days, each rat was weighed, blood samples were taken from one rat
in each group, and the administration of the experimental drugs was
begun.

Sacrificing took place at the end of one week and prior to this

weight determinations were again made on the animals.

Pre and post-in-

jection weights are recorded in table III-1.
It can be seen that the animals in Group I (saline administered
controls) experienced an average gain in weight of 11.5 grams. Rat no.
5 was the only animal in this group to lose weight, and this amount was
negligible (1 gram) .

The rats in Group II who received 200 USP units of

parathyroid hormone every other day only realized an average weight gain
of 3.8 grams.

The experimental animals in Group III receiving 5 mg of

hydrocortisone per injection and Group IV, the parathyroid hormone and
hydrocortisone group, experienced average weight losses of 2.5 and 23.5
grams respectively.
B.

BLOOD CHEMISTRY DATA
Blood samples (10 ml each) were taken from one rat in each group
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Table III-1
Weight (grams)
Rat 5
pre
post
311
310

Rat 6
pre
post
227
233

261

228

244

263

252

248

223

298

308

174>'<

-

+ 3.8

269

246

208

207

209

211

229

221

229

216

275"1<

-

-

256

242

260

235

203

170

268

244

251

222

295*

-

- 23.5

233

245*

240

Group III
234
(Hydrocortisone)

262*

210
Group IV
(PTH + Hydrocortisone)

194*

Group II
(PTH)

*

Average
gain/loss
+ 11.5

Rat 4
pre
post
273
259

Rat 2
pre
post
266
278

Group I
(saline)

Rat 7
pre post
269>'<
-

Rat 3
pre
post
253
240

Rat 1
pre
post
204
229*

2.5

Rats used for blood samples via cardiac puncture (see table III-2)

t-'
1.0

20
at random prior to the experimental injections, and then prior to sacrifice.

The data collected from these animals (indicated in table III-1)

selected for serum analyses of calcium (Ca++), inorganic phosphate (Pi),
and lead (Pb) can be visualized in table III-2.
A marked difference can be seen between the pre and post-injection
blood levels of Pb: pre-injection levels averaged 9.2
serum, while post injection levels averaged 36.4
a difference of 27.2

~g

~g

~g

per 100 ml

per 100 ml serum;

%.

Pre-injection levels of calcium in all the experimental animals
averaged 11.88 mg per 100 rnl serum.

The serum calcium level of the

animal in Group I remained, for all practical purposes, unchanged (averaged 10.8 mg %) throughout the whole of the experimental period.

The

rat from Group II demonstrated a slightly elevated calcium level from
12.5 mg per 100 ml serum to 13.85 mg per 100 ml serum (averaging the
two post-injection measurement levels) representing a slight gain of
1.35 mg %.

The rat from Group III (hydrocortisone), however, showed an

increased serum calcium level of 2.6 mg % which was 1.25 mg per 100 ml
of serum greater than the final value obtained from the PTH injected
animal.

Finally, the measured values obtained from the Group IV rat

were as follows: pre-injection= 13.0 mg %;

post~injection

= 16.88 mg %.

This demonstrates a difference of 3.88 mg per 100 ml of serum which
proved to be 3.02 mg greater than the Group II rat and 3.45 mg greater
than the Group III rat (post-injection levels).
Pre-injection inorganic phosphate levels of all animals averaged
4.6 mg per 100 ml of serum.

The pre and post-injection levels of Pi
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Table III-2

Blood Analysis
- mg % ca++ and Pi)

(~g % Ph

Group I
(Saline)

pre
10.5

Ph
post
30.5

ca++
pre
post
11.2
10.45

pi
pre- post
3.30
3.8

Group II
(PTH)

8.6

38.3

12.5

13.2014.50

5.6

1.051.10

Group III
(Hydrocortisone)

5.5

32.6

10.8

12.8014.05

3.9

4.05
4.25

12.2

44.2

13.0

16.8516.90

5.2

1.02

Group IV
(PTH +Hydrocortisone)
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for the Group I rat remained essentially unchanged; 3,8 mg % and 3.3
mg % respectively.

The Group II rat showed a difference of 4.5 mg %,

representing a loss of phosphate when compared to the pre-injection
level, which was 2.23 mg% less than that of Group I.

The Group III

rat showed little or no change from its pre-injection level of 3.9 mg
per 100 ml serum to its post-injection level of 4.15 mg per 100 ml
serum, a difference of only +0.25 mg %.

Finally, the Group IV (PTH-

cortisol) rat, whose pre-injection serum Pi level was 5,2 mg % realized a post-injection 4.2 mg % difference to 1.02 mg per 100 ml of
serum.
C.

HISTOLOGIC DATA
Lead intoxication as demonstrated by the high blood levels was

verified by the red staining of the insoluble lead salts intranuclearly
with the sodium rhodizonate (Figures III-1 and III-2),

The strength of

staining may be compared to Figures III-3 and III-4 where the lead of
the pencil tip markings identifying the slide were allowed to leach onto
the tissue sections during the staining process.
mens stained a deep scarlet red.

The resultant speci-

The light green S.F. counterstain com-

pletely masked the rhodizonate staining of the lead salts as demonstrated
in Figures III-5 and III-6.
The hematoxylin and eosin stained sections of alveolar process and
head of the femur were unremarkable.

However, the rib and condyle his-

tologic sections showed some differences between the four groups.
The PTH injected animals (Group II) showed a widening of the band
of calcifying cartilage and zone of hypertrophy.

There was also an in-

crease in the number of cartilage columns and an increase in the marrow

23
space cellularity with a concomitant decrease in the amount of calcification and ossified structures.
Ill-10, III-11, and Ill-12.

This may be visualized in Figures

The lead intoxicated saline controls by

comparison appear in Figures III-7, III-8, and III-9.

Cortisol therapy

in the Group III rats (Figures III-13, III-14, III-15, and III-16)
caused a marked thinning of the proliferative (calcifying) and hypertrophic cartilage in the rib and condyle.
peared encased in the ossifying matrix.
cation.

The cartilage columns apThere was also decreased ossifi-

In Group IV where the rats received PTH and cortisol the sec-

tions approached a medium between the controls and the PTH group. There
was less calcification and there was a slight increase in the marrow
space cellularity as compared to the controls.
trated in Figures III-17, III-18, and III-19.

These changes are illus-
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Figure III-1

Sodium rhodizonate stain - rib

lOOX
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Figure III-2

Sodium rhodizonate stain - head of femur

lOOX
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Figure III-3

Lead leaching from pencil markings
onto tissue sections
alveolar process
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Figure III-4

Lead leaching from pencil markings onto
tissue sections - alveolar process

lOOX
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Figure III-5

S.F. counterstain - rib

lOOX
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Figure III-6

S.F. count e rstain- h e ad of femur

lOOX
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Figure III-7

Group I - saline control - rib

lOOX
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Figure III-8

Group I - saline control - rib

200X
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Figure III-9

Group I - saline control - condyle

lOOX
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Figure III-10

Group II - PTH - rib

lOOX
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Figure III-11

Group II - PTH - rib

200X
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Figure III-12

Group II - PTH - condyle

lOOX
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Figure III-13

Group III - Cortisol - rib

lOOX
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Figure III-14

Group III - Cortisol - rib

lOOX
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Figure III-15

Group III - Cortisol - rib

200X
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Figure III-16

Group III - Cortisol - condyle

lOOX
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Figure III-17

Group IV - PTH + Cortisol - rib

lOOX
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Figure III-18

Group IV - PTH + Cortisol - rib

200X
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Figure III-19

Group IV - PTH + Cortisol - condyle

lOOX

CHAPTER IV

DI SCUSSION

While t he in i tial thrust of this investigation was to study the
effec t s o f corti s ol and parathyroid hormone (PTH), alone and in combina tion with each other, on bone in the lead intoxicated albino rat,
t wo a r ea s , initially assigned minor importance, surfaced >.Jith some int e r esting r esults.

One area deals with the we ight of the animals, and

the ot he r is rel a ted to serum levels of calcium (ca++-), phosphate (Pi),
and lead (Pb) .
Da ta reflecting weight changes is

reported in Table III-1, where

the controll e d Group I demonstrated a mean increase in weight of 11.5
grams.

This r e presents only a 4.4 % inc rease over th e ir initial weights.

Group II, those animals receiving PTH, shmved a weig ht g a in of onl y 1.5%
of their initial mea n value; the ir actual mean increase was 3.8 g rams.
In terms of weig ht gain or los s , Groups III and IV faired worse than
those in Groups I and II, in fact the former lost weight.

Group III,

those receiving cortisol, lost an average of 2.5 grams, which is not
considera bly g r e at when compared to 23.5 gram loss demonstrated by
Group IV, who received the combined PTH-cortisol injections.
from Gr oups III a nd IV
lit e r a tur e .

The data

is not inconsistent with that reported in the

According to Be rnick and Ershoff (1963), the administr a -

tion of cort is one to r a t s r esults in a reduction in food intake by
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these animals, and negative nitrogen balance.

Earlier, Bavetta, Ber-

nick, and Ershoff (1959) maintained rats on a qualitatively adequate
diet which was limited to approximately 5 grams per day.

They were

able to show that these rats fed this low caloric diet did not necessarily lose

weight, but had their weights plateau.

Comparatively, the animals in Groups I and II (saline controls
and PTH injected rats, respectively) did show a little gain in weight
of +11.5 grams and +3.8 grams respectively.

They were allowed food and

water freely, and should have shown greater weight gains than those observed.

However, it should be reiterated at this point that their ground

Purina Fox Chow food was adulterated with lead acetate (Pb=lOOO ppm),
1.1 percent Ca, and 1.0 percent Pi after the manner of Hsu, Krook, and
Pond (1973).

The ingestion of the heavy metal Pb might account for

this almost catabolic effect with respect to their weights.

One of the

numerous symptoms of chronic lead poisoning is anorexia, which perhaps
helps to explain the lack of weight gain in the first two groups.
Upon analyzing the data obtained from pre and post-injection blood
samples, tested for ca++, Pi• and Pb, it was of interest to note that
the pre-injection blood levels of ca++ and Pi were all within their normal ranges (ca++, mean= 11.8 mg/100 ml serum; Pi, mean = 4.8 mg/100 ml
serum).

On the other hand, pre-injection Pb values appeared to be rel-

atively inconsistent (see Table III-2) with a mean value of 9.2 ~g/100
ml serum which, according to Berkow (1977), appears to be insignificantly low, and relative to human beings, low enough not to be toxic
(normal non-toxic human level 15 to 40

~g

%) .

While these values appear
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to be low, it should be pointed out that these animals had only been
exposed to the lead in their diet for a period of only one week, a time
period certainly not long enough to be considered toxic,

However, at

the end of the experimental period, the serum Pb values had increased
by some 76 percent over their original values, putting the animals at
the lower limits of chronic lead intoxication.

In the beginning of

this study, it appears obvious that the low borderline toxic levels of
Pb had little or no effect on serum ca++ or Pi levels in all groups,
especially Group I rats.

Group II animals receiving PTH demonstrated

a rise in serum ca++ of 1 to 2 mg over their pre-injection levels, but
a fall of approximately 4.5 mg of Pi compared to the pre-injection
levels.

These effects of parathyroid hormone on ca++ and Pi are well

known and consistent with the literature with the exception of the very
slight hypercalcemia, observed in this group, which is believed to be
due to suppression of mobilization of ca++ from bone due to the presence of low, toxic Pb concentrations.
The animals in Group III receiving cortisol demonstrated a rise
in serum ca++ to the order of 2.85 mg %, representing a 20 percent increase over their pre-injection level.

However, there was no apprecia-

ble difference between pre-injection and post-injection levels of Pi.
While this data is somewhat in agreement with the literature, one cannot help but feel that the presence of Pb might have prevented some
dramatic disclosures in this group of animals.
Finally, Group IV rats receiving PTH and cortisol do show some
dramatic differences between pre and post-injection levels of ca++ and
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Pi.

This group demonstrated a marked increase in Ca++ levels to the

order of 22.8 percent higher than its pre-injection levels, and slightly higher than the post-injection levels of Groups II and III (3.02 mg
and 3.22 mg respectively).

The observation that the post-injection ca++

concentration of 16.87 mg per 100 ml serum was higher in Group IV than
the post-injection level of Group II which was observed to be 13.85 mg
per 100 ml serum can only be explained on the basis of the presence of
the Pb.

According to Bentzel, Carbone, and Rosenberg (1964), Lazor and

Rosenberg (1964), and Mundy and Raisz (1974) glucocorticoids have been
shown to be effective in the treatment of hypercalcemia associated with
hematological neoplasms, however, their mechanism of action remains undefined to any real degree of satisfaction (Strumpf, Kowalski, and
Mundy 1978).

The post-injection Pi level, while markedly lower than

the pre-injection level (4.18 mg), was almost identical to the pre and
post-injection levels of Group II.
Upon reflecting, one cannot help but to consider the presence of
Pb to be a factor responsible for the results obtained relative to the
weights of the animals, their serum ca++ and Pi levels, and even the
changes in Pb levels under the influence of PTH, cortisol, and PTH +
cortisol.

Earlier chronic Pb studies, ranging from 9 to 20 weeks, al-

lowed time for the toxic effects of the heavy metal to set in, while the
basic idea in this study was to have a low grade of toxicity develop
over a very short period of time (2 weeks) in order to see if this "subliminal" toxicity had a greater or lesser effect in the areas under
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investigation.

The number of bizarre findings in this study are quite

intriguing and suggests further extension of this study relative to the
use of larger and varying doses of both PTH and cortisol; extension of
the time of lead exposure prior to, and/or during administration of the
hormones.

A final avenue would include: samples of epiphyses of long

bones, ribs, and sections of liver and kidney.

The use of rhodizonate

should not be abandoned, but the manner of decalcification of hard tissue should be further investigated due to the presence of artifacts in
the specimens possibly caused by the use of sulfuric acid.

As reported

by Pearse (1960) the rhodizonate method is quite sensitive for lead:
"In practice I have found that small concentrations of an insoluble
lead salt (PbS04) in the tissues can readily be demonstrated by the rhodizonate method."

These insoluble lead salts are transformed from solu-

ble Pb deposits in the bone by the decalcification procedure utilizing
(Gomori, 1952).
Histologically, the results in this experiment are consistent with
past literature.

Group II, the PTH injected animals, showed a decrease

in the amount of calcification in growth areas (rib and condyle).

As

reported by Yonaga (1978) on sections of rat proximal tibia sections,
the rib and condyle sections of Group II showed a widening of the cartilaginous plate and a widening of the hypertrophic cell layer.

There

was also increased cellularity in the marrow spaces with a decrease in
ossification.

Laron, Muhlethaler, and Klein (1958) reported that para-

thyroid extract produces changes expected from excess parathyroid hormone.
There was interference with normal calcification and hypercalcemia.
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The Group III histologic studies also concurred with past references (Follis, 1951; Sissons and Hadfield, 1955; Laron, Muhlethaler,
and Klein, 1958; Bernick and Ershoff, 1963; Jee, Park, Roberts, and
Kenner, 1973).

There was a narrowing of the cartilaginous growth zones

(rib and condyle) and an encasement of the cartilage columns in the ossifying matrix.

There was also a decrease in the amount of calcifica-

tion taking place.

It seemed that the whole process of cartilage chang-

ing into mature bone was at a standstill.

As Bernick and Ershoff re-

ported in 1963, "one may conclude that cortisone, by its action upon the
acid mucopolysaccharides, alters the ground substance of bone, thus inhibiting its proper calcification, its physiologic resorption and, therefore, its reorganization".
This reduction in bone activity is time and dose dependent as reported by Jee, Park, Roberts, and Kenner in 1973.

Low doses of cortisol

(1 and 5 mg/kg/day) reduce bone through increased bone resorption and
high doses (20 and 75 mg/kg/day) depress bone resorption in rats.

Also

noted by Roberts in 1969 was that at the high dose levels of cortisol,
progenitor cell proliferation and bone formation were depressed without
any evidence of increased resorption of bone, and at low doses the corticosteroid action was characterized by increased progenitor cell proliferation, increased number of osteoclasts, and increased resorption
of bone.

The histology presented by the rats in Group III is consistant

with the data presented by Roberts.

The rats in Group III received 5

mg every other day for seven days.

The average weight of the rats over

the experimental period was approximately 250 grams, therefore, the
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dose averaged out to 20 mg/kg/injection, which according to the previous studies would appear on the low end of the high dose level spectrum.

Sissons and Hadfield (1955) reported a retardation of bone

growth and organization with this "high" dose of cortisol.
When both hormones were given simultaneously the results obtained
histologically demonstrated an antagonistic action between cortisol and
PTH.

The blood chemistry levels do not verify this but, again, this

may be due to the presence of Pb which has an osteolytic effect upon
bone.

The dosage of cortisol plays an important role here.

As report-

ed by Roberts (1969) at low doses cortisol induces a secondary hyperparathyroidism which results in increased bone resorption.

In this case,

the effect of exogenous and endogenous PTH would be cumulative.

At the

higher doses though, the inhibitory effect of the corticosteroid takes
precedence and the hormonal antagonism occurs,
PTH effect was evident in the Group IV rats.

This resultant minimal

SUMMARY AND CONCLUSIONS
The data obtained during this study showed a definite effect on
ca++ and Pi metabolism as reflected by the serum studies on all of the
animals treated with PTH, cortisol, and PTH

+

cortisol, some consistent

with the prevailing literature in the presence of a lead intoxication
of a very low grade.

The weights of the test animals were affect like-

wise: although subtle (possibly due to the time and dosage parameters),
histologic changes in bone also occurred.

Relative to the few incon-

sistencies noted between the data presented in this paper and the past
literature, the low lead dose and time exposure as well as the doses of
the hormones administered may have had an effect.

These experiments

should be extended and further investigations undertaken in the manner
suggested in Chapter IV.
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